- An overview of general chapter development for oral and nasal drug products (OINDPs) at the US Pharmacopeia (USP): Part 2—Informative chapters <1601>, <1602>, <1603> and <1604>
- An overview of general chapter development for oral and nasal drug products (OINDPs) at the US Pharmacopeia (USP): Part 1—Normative chapters <5>, <601>, <602>, <603> and <604>
- The Abbreviated Impactor Measurement (AIM) and Efficient Data Analysis (EDA) concepts: Why they are important and how to work with them
- Significant advances in laboratory testing of orally inhaled products during the ten-year life of Inhalation
- Quality by design: Considerations for inhalation product development
- Measuring the cold freon effect
- Innovation in analytical tools: More signal and less noise in particle size testing of inhaled products
- Developing OINDPs using Quality by Design
- Applying QbD principles to device selection